News

ARX-04 is a proprietary non-invasive, fast-onset sublingual product for the treatment of moderate-to-severe acute pain. As per the terms of the grant, the USAMRMC is expected to support

The expanded agreement allows IDBS to provide direct access to extended cheminformatics capabilities from IDBS chemistry and data management solutions to the customers. Moreover, IDBS chemistry customers will

Under the indefinite delivery, indefinite quantity (IDIQ) contract, PPD will offer global regulatory and biostatistical services for a range of clinical development programs to the US Army. PPD

Neurontin is used alone or in combination with other medications to treat seizures caused by epilepsy in adults and children who are at least 12 years old. The

As per the deal, Clearstone will provide LabCorp with central laboratories and clinical trials management system Apollo CLPM, which provides clients with real-time access to automate sample stability

The new facilities consist of instrumentation, organic and analytical chemistry laboratories, office space for newly created scientific positions, conference rooms and employee common areas. Triclinic is set to

Jointly developed by Affymax and Takeda, peginesatide is a synthetic, PEGylated peptidic compound that binds to and activates the erythropoietin receptor and thus acts as an erythropoiesis stimulating

AMR101 is a prescription-grade omega-3 fatty acid indicated for the treatment of patients with very high triglyceride levels (>500 mg/dL) and as a potentially first-in-class therapy for patients

The remaining minority share of Ubichem Research remains in the ownership of Jozsef Repasi, managing director of Ubichem Research. Following the acquisition, Ubichem Pharma Services will continue to